CDK9 and lymphopenia: As observed in our model, treatment of patients with nonspecific CDK9 inhibitors (e.g., flavopiridol, P276-00, and roscovitine) can cause gastrointestinal mucositis, cardiac complications, weight loss, and mild lymphopenia (32, , , –36, 40, –42).